Long-term safety and efficacy of voclosporin in black patients with lupus nephritis: Results from the AURORA 1 and AURORA 2 studies (UKKW 2024) - Jun 8, 2024 - Abstract #375; 194; Location: HARRIS; P3 | "Voclosporin in conjunction with low-dose glucocorticoids and mycophenolate mofetil (MMF) has shown significant benefit across ancestries and classes of LN. Conclusion Black patients treated with a voclosporin-based regimen achieved higher rates of renal response than patients treated with MMF and glucocorticoids alone. For patients entering the continuation study, the response was largely durable for up to 3 years."
Clinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Dr Gabriel Contreras1; Dr Matt Baker2; Dr Lucy Hodge2; Dr Ernie Yap2; Mohamed Ahmed3
|